Research progress and therapeutic strategies in hepatocellular carcinoma metabolic reprogramming
{{output}}
Background: Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality worldwide, with therapeutic resistance posing a significant clinical challenge. Metabolic reprogramming, a hallmark of cancer, enables... ...
